Terms: = Liver cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
118 results:
1. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract] [Full Text] [Related]
2. Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysis.
Hu R; Xu J; Wang H; Wang J; Lei K; Zhao X; Zhang H; You K; Liu Z
BMC Cancer; 2024 Feb; 24(1):190. PubMed ID: 38336712
[TBL] [Abstract] [Full Text] [Related]
3. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
[TBL] [Abstract] [Full Text] [Related]
4. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
[TBL] [Abstract] [Full Text] [Related]
5. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Wainberg ZA; Melisi D; Macarulla T; Pazo Cid R; Chandana SR; De La Fouchardière C; Dean A; Kiss I; Lee WJ; Goetze TO; Van Cutsem E; Paulson AS; Bekaii-Saab T; Pant S; Hubner RA; Xiao Z; Chen H; Benzaghou F; O'Reilly EM
Lancet; 2023 Oct; 402(10409):1272-1281. PubMed ID: 37708904
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic accuracy of magnifying chromoendoscopy in the assessment of tumor invasion depth in early colorectal cancer: a systematic review and meta-analysis.
Huang Y; Yang Z; Yao Y; Liu G; Chen R
Tech Coloproctol; 2023 Dec; 27(12):1155-1167. PubMed ID: 37474693
[TBL] [Abstract] [Full Text] [Related]
7. Optimization of Neferine Purification Based on Response Surface Methodology and Its Anti-Metastasis Mechanism on HepG2 Cells.
Wang X; Wei Z; Hu P; Xia W; Liao Z; Assani I; Yang G; Pan Y
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446748
[TBL] [Abstract] [Full Text] [Related]
8. CDCA8 Facilitates Tumor Proliferation and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Cui Y; Jiang N
Appl Biochem Biotechnol; 2024 Mar; 196(3):1481-1492. PubMed ID: 37428386
[TBL] [Abstract] [Full Text] [Related]
9. The dynamics of telomere length in primary and metastatic colorectal cancer lesions.
Kroupa M; Kubecek O; Tomasova K; Hanak P; Krupova M; Cervena K; Siskova A; Rosendorf J; Hosek P; Vodickova L; Vodicka P; Liska V; John S; Vymetalkova V; Petera J
Sci Rep; 2023 Jun; 13(1):9097. PubMed ID: 37277368
[TBL] [Abstract] [Full Text] [Related]
10. Interleukin-22 promotes the proliferation and migration of hepatocellular carcinoma cells via the phosphoinositide 3-kinase (PI3K/AKT) signaling pathway.
Mansur F; Arshad T; Liska V; Manzoor S
Mol Biol Rep; 2023 Jul; 50(7):5957-5967. PubMed ID: 37264148
[TBL] [Abstract] [Full Text] [Related]
11. Two fragments of HBV DNA integrated into chrX: 11009033 and its genetic regulation in HepG2.2.15.
Ruan P; Zhou R; He C; Huang C; Lin M; Yin H; Dai X; Sun J
Mol Med Rep; 2023 May; 27(5):. PubMed ID: 36960866
[TBL] [Abstract] [Full Text] [Related]
12. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract] [Full Text] [Related]
13. Gold Nanosystems Covered with Doxorubicin/DNA Complexes: A Therapeutic Target for Prostate and liver cancer.
Giráldez-Pérez RM; Grueso E; Montero-Hidalgo AJ; Luque RM; Carnerero JM; Kuliszewska E; Prado-Gotor R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555216
[TBL] [Abstract] [Full Text] [Related]
14. In Silico and In Vitro Studies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the treatment of Hepatocellular Carcinoma.
Wu Z; Kang J; Tan W; Wei C; He L; Jiang X; Peng L
Comput Math Methods Med; 2022; 2022():8669993. PubMed ID: 36345477
[TBL] [Abstract] [Full Text] [Related]
15. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
Liu S; Zheng Q; Zhang R; Li T; Zhan J
Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
[TBL] [Abstract] [Full Text] [Related]
16. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma.
Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM
Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415
[TBL] [Abstract] [Full Text] [Related]
17. 13 C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Gairing SJ; Kuchen R; Müller L; Cankaya A; Weerts J; Kapucu A; Sachse S; Zimpel C; Stoehr F; Pitton MB; Mittler J; Straub BK; Marquardt JU; Schattenberg JM; Labenz C; Kloeckner R; Weinmann A; Galle PR; Wörns MA; Foerster F
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00529. PubMed ID: 36087052
[TBL] [Abstract] [Full Text] [Related]
18. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/rhoa pathways.
Zhao M; Wang Y; Zhang Y; Li X; Mi J; Wang Q; Geng Z; Zuo L; Song X; Ge S; Zhang Z; Tang M; Li H; Wang Z; Jiang C; Su F
BMC Gastroenterol; 2022 Aug; 22(1):378. PubMed ID: 35941537
[TBL] [Abstract] [Full Text] [Related]
19. Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinoma.
Malone CD; Egbulefu C; Zheleznyak A; Polina J; Karmakar P; Black K; Shokeen M; Achilefu S
Sci Rep; 2022 Jul; 12(1):12748. PubMed ID: 35882949
[TBL] [Abstract] [Full Text] [Related]
20. Design, synthesis and antitumor evaluation of novel 1H-indole-2-carboxylic acid derivatives targeting 14-3-3η protein.
Gao Z; Fan T; Chen L; Yang M; Wai Wong VK; Chen D; Liu Z; Zhou Y; Wu W; Qiu Z; Zhang C; Li Y; Jiang Y
Eur J Med Chem; 2022 Aug; 238():114402. PubMed ID: 35525080
[TBL] [Abstract] [Full Text] [Related]
[Next]
